Genetic Screening and Its Role in Embryo Selection for IVF
- Apr 17, 2025
- 4:00PM TO 5:00 PM
- 00Days
- 00Hours
- 00Minutes
- 00Seconds
About the Case Presentation
Genetic screening plays a crucial role in the process of embryo selection for in vitro fertilization (IVF) by identifying potential genetic disorders in embryos before implantation. This screening, often referred to as preimplantation genetic testing (PGT), involves analyzing embryos for chromosomal abnormalities or specific genetic mutations. It helps in selecting the healthiest embryos, reducing the risk of passing on inherited conditions, and increasing the chances of a successful pregnancy. PGT can identify conditions such as Down syndrome, cystic fibrosis, and certain inherited cancers, allowing parents to make informed decisions about which embryos to implant. This technology enhances the overall outcome of IVF by improving the quality of embryos and reducing the likelihood of miscarriage. Ultimately, genetic screening offers a valuable tool for optimizing reproductive success and promoting healthier pregnancies.
About the Speaker
Dr. Yolanda Cabello,
Senior Clinical Embryologist, VIU, Madrid, Spain
Dr. Yolanda Cabello is a seasoned professional in the fields of assisted reproduction, clinical psychology, and quality management, with a dynamic international career spanning Europe, the USA, South America, the Middle East, and Indonesia. She currently works as a freelance Scientific Advisor, Assisted Reproduction Consultant, Quality Auditor, and Psychologist, contributing her expertise globally since September 2023. She also serves as a University Professor for the Master’s in Health Management and Clinical Leadership at VIU – Universidad Internacional de Valencia, and as a secondary school science teacher at Montessori International School in Madrid, where she integrates holistic education with personal life values. Dr. Cabello has extensive experience in quality systems, holding auditor certifications for ISO standards (9001, 13485, 14001, and 45001), and has previously worked as Lab Co-Director and Scientific Advisor at IVF-Life. Academically, she holds a PhD in Medical Sciences (awarded Sobresaliente Cum Laude) from Universitat de les Illes Balears, and an MBA in Business and Health Management from thePower Business School. Her multifaceted expertise and commitment to both patient care and education make her a prominent figure in reproductive medicine and clinical excellence.